Bill 4 (Peter Kormos Memorial Act) amends the Gift of Life Act to allow removal and use of human tissue after death by default unless an objection has been recorded by the person (16+) or by an eligible substitute, and it requires parental consent for children under 16. The measure repeals the statutory definition of “consent” and accepts objections or consents in multiple formats, while assigning Ontario Health (the Agency) the job of maintaining a central registry of objections and consents and coordinating designated facilities.
The change shifts the default from explicit pre‑death consent toward a structured opt‑out regime and creates operational requirements for hospitals and other designated facilities to notify the Agency and, where directed, attempt contact with patients or their substitutes. That combination raises immediate compliance, privacy, and clinical time‑sensitivity issues for transplant programs, coroners, and health administrators while aiming to increase tissue availability for transplants, research and education.
At a Glance
What It Does
The bill permits post‑mortem removal and use of tissue by default unless a person (16+) has objected or, for children under 16, their parent or guardian has not consented. It establishes acceptable objection/consent methods (signed writing, oral with two witnesses, recorded electronic messages) and requires communication of objections/consents to an attending physician or the Agency.
Who It Affects
Designated facilities (hospitals, coroners, funeral service holders), transplant and tissue banks, Ontario Health (the Agency) and its staff, parents/guardians of minors, and potential recipients and researchers relying on tissue donations. It also implicates coroners and persons lawfully holding a body under existing statutes.
Why It Matters
This is a structural change from explicit consent toward an opt‑out framework, combined with a provincial registry and active obligations on facilities — a shift likely to increase available tissue but to create new workflow, legal, and data governance burdens for health systems and family decision‑makers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill rewrites the post‑mortem provisions of the Gift of Life Act so that tissue removal for therapeutic, educational or research uses is permitted by default after death unless a valid objection exists or, when the deceased is a child under 16, a parent or guardian has not given consent. It removes the Act’s statutory definition of “consent” and replaces a narrow, opt‑in model with an opt‑out regime that recognizes multiple ways to register objections or consents.
Any person aged 16 or older may object to post‑mortem removal at any time prior to death (including during last illness). The bill prescribes three formats for objections or consents: signed writing, an oral statement witnessed by two people, or a recorded electronic message (for example email or recorded telephone).
Those objections or consents must be communicated to an attending physician or to “the Agency” (the statutory designation used in the Act), which the Connecting Care Act amendments make clear refers to Ontario Health for the coordination role.If someone dies without an objection, a defined hierarchy of substitutes may object on the deceased’s behalf: spouse, a child, a parent, a sibling, other next of kin, and finally certain persons lawfully in possession of the body (administrative hospital head, coroner, Public Guardian and Trustee, embalmer/funeral director, or crematorium superintendent). The bill bars substitutes from objecting if they have reason to believe the deceased would not have objected.
Designated facilities must notify the Agency when a patient dies or when death is imminent; the Agency decides whether a facility must attempt to contact the patient or substitute, and if so the facility must make reasonable efforts using Agency‑specified methods and personnel.To support the new regime, the bill amends the Connecting Care Act to give Ontario Health responsibility for planning and coordinating tissue‑removal activities and requires Ontario Health to establish and maintain a registry of objections and consents. Names must be entered promptly and the registry must indicate whether an objection or consent covers all tissue or only specified parts.
The bill also repeals or replaces several existing provisions (including sections on the definitions and certain procedural text) to align statutory language with the opt‑out approach.
The Five Things You Need to Know
The bill makes post‑mortem removal and use of tissue permissible by default for adults unless an objection has been made by the person (aged 16+) or by an eligible substitute after death.
Persons 16 and older may register an objection at any time by signed writing, an oral statement witnessed by two people, or a recorded electronic message; objections must be communicated to an attending physician or the Agency.
If a person has not objected, a hierarchy of substitutes (spouse, child, parent, sibling, next of kin, then certain holders of the body) may object on the person’s behalf, but substitutes may not object if they have reason to believe the deceased would not have objected.
Designated facilities must notify the Agency when death occurs or is imminent; the Agency determines whether the facility must try to contact the patient or substitute, and if required the facility must make reasonable efforts using Agency‑prescribed contact methods and personnel.
Ontario Health must establish and promptly maintain a registry of objections and consents and record whether the objection/consent covers all tissue or only specified parts.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Repeal of statutory definitions for consent and writing
The bill removes the Gift of Life Act’s formal definitions of “consent” and “writing.” Practically, this allows the Act to accept a broader set of objection/consent mechanisms (including recorded messages and witnessed oral statements) rather than constraining parties to a single statutory form. It also delegates precision about acceptable formats and authentication to operational practice and regulations, increasing reliance on Ontario Health guidance and facility protocols.
Opt‑out post‑mortem removal, objection formats, and substitute decision‑making hierarchy
These provisions flip the post‑mortem rule: tissue removal is permitted unless the deceased objected or, for children under 16, a parent/guardian did not consent. The bill prescribes three acceptable formats for objections/consents (signed writing, oral with two witnesses, recorded electronic message) and requires communication to an attending physician or the Agency. It also sets a clear order of substitutes who may object after death and adds a prohibition preventing someone from objecting on behalf of the deceased if they have reason to believe the deceased would not have objected — a subjective test that will be operationally significant.
Obligations on designated facilities and Agency determinations
The bill tightens responsibilities for designated facilities: when they notify the Agency of death or imminent death, the Agency will decide whether the facility must contact the patient or substitute about objections/consents. If the Agency requires contact, the facility must make reasonable efforts and follow Agency and Ministerial requirements (including who may make the contact). That creates a delegated decision point — the Agency’s determination triggers specific, enforceable operational duties on facilities.
Ontario Health given coordinating and registry duties
Amendments to the Connecting Care Act assign Ontario Health responsibility for planning, coordinating and supporting tissue removal and transplantation activities and for coordinating designated facilities’ work. They also explicitly instruct Ontario Health to create and maintain the objections/consents registry described in the Gift of Life Act amendments, embedding the registry function in the provincial health‑system governance structure.
Mandatory registry of objections and consents
This new statutory part requires the Agency to create a registry, enter names promptly when objections/consents arrive, and indicate whether the entry applies to all tissue or only specified parts. The statutory promptness requirement establishes an administrative duty but leaves details — verification, correction, data access, retention and security — to implementing rules and Ontario Health procedures.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Potential transplant recipients and waiting‑list programs — expanding the default supply of tissue should increase availability for transplants and reduce time pressures associated with locating donor consent.
- Transplant coordinators and tissue banks — clearer default rules and a central registry simplify source verification when an objection is absent or when time is short.
- Ontario Health (the Agency) — gains statutory authority to coordinate transplant activities and control a centralized registry, enhancing provincial planning capability and data aggregation for program management.
- Medical education and researchers — broader lawful access to post‑mortem tissue (subject to recorded objections) could support training and research sampling that previously depended on explicit consent processes.
Who Bears the Cost
- Designated facilities (hospitals, transplant teams) — must implement notification workflows, attempt mandated contacts, train personnel to meet Agency/Minister requirements, and reconcile registry data under time pressure, all of which increase operational and staffing costs.
- Families and substitutes — face new obligations to track deceased relatives’ stated wishes and may be placed in adversarial positions when called to decide under stressful circumstances, particularly where family members disagree.
- Ontario Health/Agency — must stand up and run a prompt, secure registry, develop contact protocols and guidance, and make determinations for facilities, imposing staffing, IT and governance costs.
- Coroners, funeral directors and other persons lawfully in possession of bodies — face potential new legal and ethical responsibilities as last‑resort decision‑makers and may need to reconcile their statutory duties with substitute objections and Agency directions.
Key Issues
The Core Tension
The bill balances increasing tissue availability (and potential lives saved) through a presumed‑permissive default against protecting individual autonomy and family decision‑rights: easing access for transplant programs risks overriding or complicating private wishes and places operational burdens on families and health systems, while leaving authentication, timing and data governance questions unresolved.
The bill packs significant operational change into a short statutory text and leaves many implementation details to the Agency, regulations and facility practice. Key unresolved questions include how the registry will authenticate and reconcile conflicting entries, how quickly names will be published or queried in time‑sensitive transplant windows, and what procedural safeguards will govern access, correction and deletion of registry records.
The removal of formal statutory definitions for “consent” and “writing” broadens acceptable formats but increases vulnerability to disputes over authenticity (for example contested oral statements or spoofed electronic messages) unless the Agency issues strict verification standards.
The substitute‑decision hierarchy and the prohibition on objections when a substitute has reason to believe the deceased would not have objected create both ethical and evidentiary friction. “Reason to believe” is inherently subjective and could prompt litigation or conservative decision‑making that delays donation. Likewise, requiring facilities to make “reasonable efforts” to contact substitutes per Agency and Minister rules defers critical procedural clarity to future guidance; timing, scope and proof of those efforts will matter in cases where every hour affects tissue viability.
Finally, the bill’s central registry raises privacy and data‑security trade‑offs: centralization aids verification and planning but concentrates sensitive personal health and end‑of‑life data, demanding robust governance and transparent access rules that the text does not specify.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.